John F. Crowley - 01 Feb 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Executive Chairman, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
01 Feb 2023
Net transactions value
-$1,132,673
Form type
4
Filing time
03 Feb 2023, 16:46:35 UTC
Previous filing
13 Jan 2023
Next filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Options Exercise $508,331 +83,333 +8.2% $6.10 1,095,389 01 Feb 2023 Direct
transaction FOLD Common Stock Options Exercise $290,337 +56,596 +5.2% $5.13 1,151,985 01 Feb 2023 Direct
transaction FOLD Common Stock Sale $1,931,342 -147,316 -13% $13.11 1,004,669 01 Feb 2023 Direct F1, F2
holding FOLD Common Stock 64,895 01 Feb 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Options Exercise $0 -83,333 -100% $0.000000* 0 01 Feb 2023 Common Stock 83,333 $6.10 Direct F3
transaction FOLD Stock Options (right to buy) Options Exercise $0 -56,596 -100% $0.000000* 0 01 Feb 2023 Common Stock 56,596 $5.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022 for estate planning purposes.
F2 This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.81 to $13.28 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 All of these options were fully vested and exercisable as of the transaction date.

Remarks:

In addition to the reported transactions which were undertaken for estate planning purposes, Mr. Crowley also has approximately 627,000 options outstanding and exercisable at various strike prices.